semaglutide and bilirubin 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial The weight-loss-independent hepatoprotective benefits of

Research has examined glutathione and its precursor N-acetyl cysteine (NAC) and found clinical benefit in treating peripheral artery disease 2 , Parkinsons disease 3 , fatty liver 4 , coronary reperfusion injury 5 , bipolar disorder 6-7 obsessive compulsive disorder 8 , schizophrenia 6,9,10 , addiction treatment 11-12 , autism 13 and flu prevention 14

2017) as shown in Table 1

[235] Patients should watch for signs of excessive sedation, morning grogginess, dizziness, or any unusual bleeding or bruising

Lewis CR, Preller KH, Kraehenmann R, Michels L, Staempfli P, Vollenweider FX

Usually, the presenting problem(s) are minimal